Prediction of Getting Peripheral Neuropathy in Patients Treated With Bortezomib?
NCT05781425 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2025-07-31
Summary
Investigation of which patients treated with bortezomib that have increased risk of developing peripheral neuropathy.
Conditions
- Chemotherapy-induced Peripheral Neuropathy
Sponsors & Collaborators
-
Aarhus University Hospital
collaborator OTHER -
Sygehus Lillebaelt
collaborator OTHER -
University of Southern Denmark
collaborator OTHER -
Odense University Hospital
lead OTHER
Principal Investigators
-
Per Damkier · Odense University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-12
- Primary Completion
- 2025-04-24
- Completion
- 2025-07-29
Countries
- Denmark
Study Locations
More Related Trials
-
Study of the Evolution of the Expression of the LAMP-2 Protein During the Advance in Age
NCT06357923 ·Status: RECRUITING ·Phase: NA
-
Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer
NCT00826579 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient
NCT07157579 ·Status: NOT_YET_RECRUITING
-
Predictors of Node Positivity in Endometrial Cancer
NCT05793333 ·Status: RECRUITING
-
SLNM in Endometrial Cancer Combined With OSNA
NCT02826291 ·Status: COMPLETED
-
Biology and Genetics of Smouldering Myeloma
NCT05047107 ·Status: UNKNOWN
-
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
NCT01187173 ·Status: COMPLETED
-
Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression
NCT04137523 ·Status: COMPLETED
-
Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma
NCT01410981 ·Status: COMPLETED
-
Circulating Lymphatic Progenitor Cell and Lymph Node Metastasis
NCT01268956 ·Status: UNKNOWN
-
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
NCT00900302 ·Status: COMPLETED
-
"Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.
NCT05818865 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Biomarker Development for Response Prediction by DNA Mutational Analysis
NCT01855061 ·Status: TERMINATED
-
Proteomics Research of Osteosarcoma
NCT03932058 ·Status: UNKNOWN
-
Prognostic Factors for All Types of Cancer Combined
NCT00704587 ·Status: COMPLETED
-
Contrast-enhanced Ultrasound for Sentinel Node Detection
NCT07310758 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma
NCT00985699 ·Status: COMPLETED
-
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
NCT00026663 ·Status: COMPLETED
-
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
NCT02269592 ·Status: RECRUITING
-
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
NCT01919749 ·Status: COMPLETED ·Phase: NA
-
Micro Assays for HemATology Malignancies Antibody Treatment
NCT07018310 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Identification and Characterization of Predictive Factors of Onset of Bone Metastases in Cancer Patients
NCT03895216 ·Status: COMPLETED
-
Prediction of True Oligo-metastatic Disease.
NCT05806151 ·Status: RECRUITING
-
Molecular Markers in Treatment in Endometrial Cancer
NCT00598845 ·Status: UNKNOWN
-
Training Data Collection & AI Development
NCT05378854 ·Status: COMPLETED ·Phase: NA